Abstract
Abstract CT117: A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1158/1538-7445.sabcs18-ct117
Publication Date: Jul 1, 2019 |
Citations: 1 |
Abstract CT117: A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study
Join us for a 30 min session where you can share your feedback and ask us any queries you have